Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease-Reference-Cited by-同舟云学术

Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease

Published:2019-02 Issue:2 Volume:4 Page:245-256
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Bernstein David E.,Tran Albert,Martin Paul,Kowdley Kris V.,Bourliere Marc,Sulkowski Mark S.,Pockros Paul J.,Renjifo Boris,Wang Deli,Shuster Diana L.,Cohen Daniel E.,Jacobson Ira M.

Funder

AbbVie

Publisher

Elsevier BV

Subject

Nephrology

Reference39 articles.

1. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease;Kidney Int Suppl,2008

2. Extrahepatic manifestations of chronic hepatitis C virus infection;Cacoub;Ther Adv Infect Dis,2016

3. Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis;Lee;PLoS One,2014

4. A nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease;Chen;Kidney Int,2014

5. Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans;Molnar;Hepatology,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus and kidney transplantation: Recent trends and paradigm shifts;Transplantation Reviews;2022-01

2. Real-world effectiveness and safety of OBT/PTV/r and dasabuvir for patients with chronic HCV genotype 1b infection in China: A multicenter prospective observational study;Liver Research;2020-09

3. Association between hepatitis C antiviral treatment and diabetes mellitus: A case series;Official Journal of the Association of Medical Microbiology and Infectious Disease Canada;2020-06

4. Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease;BMC Nephrology;2020-01-16

5. High rate of acute kidney injury in patients with chronic kidney disease and hepatitis C virus genotype 4 treated with direct-acting antiviral agents;International Urology and Nephrology;2019-10-14